Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Immunefi (IMU) vs Ripple (XRP) Price & Performance

Price performance (Past 24H)

Key statistics

Immunefi vs Ripple — how do they compare? Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume), while Ripple trades at Rp17,820 (market cap Rp1.120,78T, Rp15,6T 24h volume). The key difference: Ripple is far larger — about 41464298.9× Immunefi's market cap, and Immunefi's circulating supply is 873,4M / 10B IMU (9%) versus 62,7B / 100B XRP (63%) for Ripple. Which is the better fit depends on your goals — on Pluang, investors hold Immunefi for 5 Days and Ripple for 69 Days on average.

IMUXRP
Market Cap
Rp27,03MRp1.120,78T
Volume (24h)
Rp39,91MRp15,6T
Circulating Supply
873,4M / 10B IMU (9%)62,7B / 100B XRP (63%)
Typical Hold Time
5 Days69 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Immunefi

IMU token shows limited market activity with a modest market cap of Rp27.03M and only 9% circulating supply. The token exhibits low trading volume and minimal network activity, with a short average hold time of 5 days indicating speculative trading patterns. Recent coverage appears to confuse this cryptocurrency with a corporate entity, creating market confusion.

Outlook remains cautious due to extremely low liquidity and market confusion with traditional equity. Key risk is entity misidentification impacting proper valuation. Opportunity exists if protocol utility develops, but current fundamentals are weak with minimal ecosystem activity.

Ripple

XRP is trading at Rp17,827, showing a bearish trend with significant selling pressure as indicated by moving averages. The token has declined 43% since early 2026, nearing potential support levels. Recent ecosystem developments include Deutsche Bank and Société Générale adopting Ripple's payment rails, and Japan's tax reforms may boost adoption. However, the market cap stands at Rp1,120.78T amid high volatility.

Overall outlook is cautious with downside risks due to technical bearishness, but long-term opportunities exist from institutional adoption and regulatory tailwinds. Key risks include prolonged downtrend, regulatory uncertainty, and low liquidity. Investors should monitor support breaks and on-chain signals for entry points.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IMU

No sentiment data available yet.

XRP
56% Buy44% Sell
Avg holding period · 69 Days

Top news

Latest headlines on both assets

About Immunefi

Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.

Read more on IMU

About Ripple

A crypto asset was created by Ripple to be a speedy, less costly and more scalable alternative to both other digital assets and existing monetary payment platforms like SWIFT. It is the native digital asset on the XRP Ledger—an open-source, permissionless and decentralized blockchain technology that can settle transactions in 3-5 seconds.

Read more on XRP